MediciNova (MNOV) Revenue & Revenue Breakdown
MediciNova Revenue Highlights
Latest Revenue (Y)
$1.00M
MediciNova Revenue by Period
MediciNova Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $1.00M | 100.00% |
| 2022-12-31 | - | -100.00% |
| 2021-12-31 | $4.04M | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | -100.00% |
| 2013-12-31 | $6.00M | 647.99% |
| 2012-12-31 | $802.58K | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2008-12-31 | - | -100.00% |
| 2007-12-31 | $263.88M | 99900.00% |
| 2006-12-31 | $263.88K | -67.18% |
| 2005-12-31 | $804.07K | 64.00% |
| 2004-12-31 | $490.28K | 100.00% |
| 2003-12-31 | - | 100.00% |
| 2002-12-31 | - | 100.00% |
| 2001-12-31 | - | - |
MediciNova generated $1.00M in revenue during NA 2023, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
MediciNova Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $-999.77M | -199.98% |
| 2023-09-30 | $1.00B | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | -100.00% |
| 2021-12-31 | $4.03B | 10755800.00% |
| 2021-09-30 | $37.50K | 100.00% |
| 2021-06-30 | - | -100.00% |
| 2021-03-31 | $4.00M | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | -100.00% |
| 2013-12-31 | $6.00M | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | -100.00% |
| 2013-03-31 | $3.26K | -90.42% |
| 2012-12-31 | $34.00K | -59.43% |
| 2012-09-30 | $83.79K | -83.03% |
| 2012-06-30 | $493.62K | 158.21% |
| 2012-03-31 | $191.17K | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2011-03-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2010-03-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2009-09-30 | - | 100.00% |
| 2009-06-30 | - | 100.00% |
| 2009-03-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2008-09-30 | - | 100.00% |
| 2008-06-30 | - | 100.00% |
| 2008-03-31 | - | 100.00% |
| 2007-12-31 | - | - |
MediciNova generated - in revenue during Q1 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
MediciNova Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ADAG | Adagene | $18.11M | $833.34K |
| MOLN | Molecular Partners | $7.04M | $2.74M |
| MNOV | MediciNova | $1.00M | - |
| ANEB | Anebulo Pharmaceuticals | - | - |
| RZLT | Rezolute | - | - |
| ANTX | AN2 Therapeutics | - | - |
| PHVS | Pharvaris | - | - |
| AVTE | Aerovate Therapeutics | - | - |
| CYT | Cyteir Therapeutics | - | - |
| ELYM | Eliem Therapeutics | - | - |
| ACRV | Acrivon Therapeutics | - | - |
| PMVP | PMV Pharmaceuticals | - | - |
| PEPG | PepGen | - | - |
| CSBR | Champions Oncology | - | $12.02M |
MNOV Revenue FAQ
What is MediciNova’s yearly revenue?
MediciNova's yearly revenue for 2023 was $1M, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing a decrease of -100.00% compared to 2021. MNOV's yearly revenue for 2021 was $4.04M, representing an increase of 100.00% compared to 2020.
What is MediciNova’s quarterly revenue?
MediciNova's quarterly revenue for Q1 2024 was $0, a 100.00% increase from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $0, a -100.00% decrease from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). MNOV's quarterly revenue for Q3 2023 was $-1B, a -199.98% decrease from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).
What is MediciNova’s revenue growth rate?
MediciNova's revenue growth rate for the last 3 years (2021-2023) was -75.23%, and for the last 5 years (2019-2023) was 0%.